Quest Laboratories Limited has re-opened the trading window for dealing in its securities with immediate effect from Tuesday, July 7, 2026. The re-opening follows the company's decision to withdraw the previous notice regarding the closure of the trading window, which was initially communicated on June 26, 2026. This regulatory development allows designated persons and promoters to resume trading in the company's shares.

The withdrawal of the closure notice is consequent to a change in the company's financial disclosure frequency. Quest Laboratories has formally intimated the exchanges regarding its decision to discontinue the voluntary submission of quarterly financial results. The company will now switch back to the statutory half-yearly financial disclosure cycle as per Regulation 33(5) of the SEBI (LODR) Regulations, 2015, which is applicable to SME-listed entities.

Due to this shift in the compliance cycle, the financial results for the quarter ended June 30, 2026, are not required to be considered or approved by the Board of Directors. The company stated that under the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and its Code of Conduct for Prevention of Insider Trading, the earlier decision to close the trading window stands revoked.

The company is also initiating the necessary process on the CDSL portal to unfreeze the PANs of Designated Persons and Promoters. These accounts were locked in connection with the financial closure of the quarter ended June 30, 2026. The unfreezing process will enable these individuals to trade in the securities once the administrative updates are completed.

Quest Laboratories Limited has confirmed that its promoters did not create any encumbrance on their shares during the financial year ended March 31, 2026. The disclosure, filed under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, was submitted to the National Stock Exchange of India on April 07, 2026. This confirmation ensures that the shareholding structure of the promoters remains unencumbered, providing clarity to investors regarding the status of promoter holdings for FY26.

The declaration was made on behalf of the promoter and promoter group by Anil Kumar Sabarwal. In the letter addressed to the National Stock Exchange of India and the Audit Committee of Quest Laboratories Limited , Sabarwal explicitly stated that no encumbrance was made directly or indirectly on the shares held by the promoters during the specified period. The filing was signed digitally by Sabarwal on April 07, 2026.

The submission was facilitated by Ayushi Taunk, the Company Secretary & Compliance Officer for Quest Laboratories Limited. The document was dispatched to the exchange to fulfill regulatory compliance requirements. The company's registered office is located in Pithampur, Dhar, Madhya Pradesh.

Key Details of the Disclosure

The following table summarizes the key information regarding the regulatory filing:

The confirmation of unencumbered shares is a mandatory disclosure intended to inform the market and maintain transparency regarding the financial commitments of the promoters. It assures stakeholders that the promoters have not pledged their shares as collateral for loans or other obligations during FY26.